The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Snake Venom PLA 2 , a Promising Target for Broad-Spectrum Antivenom Drug Development
Open accessAbstract
Snakebite envenomation is a neglected global health problem, causing substantial mortality, disability, and psychological morbidity, especially in rural tropical and subtropical zones. Antivenin is currently the only specific medicine for envenomation. However, it is restricted by cold storage, snakebite diagnosis, and high price. Snake venom phospholipase A 2 s (svPLA 2 s) are found in all kinds of venomous snake families (e.g., Viperidae, Elapidae, and Colubridae). Along with their catalytic activity, svPLA 2 s elicit a wide variety of pharmacological effects that play a pivotal role in envenomation damage. Hence, neutralization of the svPLA 2 s could weaken or inhibit toxic damage. Here we overviewed the latest knowledge on the distribution, pathophysiological effects, and inhibitors of svPLA 2 s to elucidate the potential for a novel, wide spectrum antivenom drug targeting svPLA 2 s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 SDS-PAGE profile of major venom components in the main clades of venomous snakes (adapted from [20]). (a) Families: Elapidae, subfamilies Elapinae, Laticaudinae, Hydrophiinae, and Colubrinae. (b) Family: Viperidae, and subfamilies: Crotalinae (C) and Viperinae (V). Ovals enclose some bands that are typical of protein families, based on published mass. (?) indicates hypothetical protein family or activity.](https://figures.cochat.ai/paper-figures/75223b9f6ce04521a353772cd4263c61/snake-venom-pla-sub-2-sub-a-promising-target-for-broad-spectrum-antivenom-drug-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Snake venom phospholipase A2 (svPLA2) is one of the most abundant toxin families in snake venom and plays a central role in snakebite envenomation.”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“It hydrolyzes the phospholipids of the cell membrane at the sn-2 position of the glycerophospholipids, thereby releasing free fatty acids and lysophospholipids [9].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The expanding superfamily of phospholipase A2 enzymes: classification and characterization
Six, D. A., & Dennis, E. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00105-0 · Cited by 1,358 · cited 2×
“InGroup I there are approximately 115–120 residues, 7 disulfide bonds (the unique disulfide linking residues 11 and 77), and G IA has a characteristic surface loop between residues 63 to 67 called elapidic loop [11].”
BackgroundDennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
Mishra, L. C., Singh, B. B., & Dagenais, S. (2000) · PubMed · Cited by 1,173
The phospholipase A2 superfamily and its group numbering system
Schaloske, R. H., & Dennis, E. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.07.011 · Cited by 936
Snake-bites: appraisal of the global situation.
Chippaux, J. (1998) · Europe PMC (PubMed Central) · Cited by 932
Warrell, D. A. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61754-2 · Cited by 774
Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes
Manjunatha Kini, R. (2003) · Toxicon · doi:10.1016/j.toxicon.2003.11.002 · Cited by 720 · cited 1×
“The diverse toxic effects are tightly related to the multiple functional sites on the surface of svPLA2s and their different binding receptors [25].”
BackgroundConfronting the Neglected Problem of Snake Bite Envenoming: The Need for a Global Partnership
Gutiérrez, J. M., Theakston, R. D. G., & Warrell, D. A. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030150 · Cited by 555
Gutiérrez, J. M., & Ownby, C. L. (2003) · Toxicon · doi:10.1016/j.toxicon.2003.11.005 · Cited by 444 · cited 12×
“These nonimmunoglobulin antitoxins are PLA2 inhibitors (i.e., snake blood phospholipase A2 inhibitors, sbPLIs) and are used to protect the snake from the internal or external envenomation. sbPLIs can be produced by snakes of the Elapidae, Viperidae, Hydrophidae, Colubridae and Boidae families.”
BackgroundInfluentialSnakebite envenoming from a global perspective: Towards an integrated approach
Gutiérrez, J. M., Williams, D., Fan, H. W., & Warrell, D. A. (2010) · Toxicon · doi:10.1016/j.toxicon.2009.11.020 · Cited by 355
Research works printed but not linked: 12
- 1998, Bulletin of the World Health Organization, 76, 515
- 1997, Phospholipase A2 structure and catalytic properties, 97
- 2010, Snake Venom Phospholipase A2 Enzymes, 174
- 1997, Multicomponent neurotoxic phospholipases A2, 269
- 2010, The field of reptile toxinology snakes, lizards, and their venoms, 3
- 2011, Acta Chimica Slovenica, 58, 629
- 1987, Proceedings of the National Science Council, Republic of China, Part B, Life Sciences, 11, 155
- 2011, Acta Chimica Slovenica, 58, 647
- 2000, Alternative Medicine Review, 5, 334
- 2011, Pharmaceutical Biotechnology, 18, 220
- 2006, Medicina, 66, 512
- 2009, IDrugs, 12, 585
Cited by
Senji Laxme, R. R., Khochare, S., de Souza, H. F., Ahuja, B., Suranse, V., Martin, G., Whitaker, R., & Sunagar, K. (2019) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0007899 · Cited by 195
“While the mechanism of action of some of the snake venom toxins have been extensively studied [70, 79, 80], others, especially the least abundant toxins, remain chiefly underinvestigated.”
BackgroundCytotoxicity of snake venom enzymatic toxins: phospholipase A2 and l -amino acid oxidase
Hiu, J. J., & Yap, M. K. K. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200110 · Cited by 149
Catalytically Active Snake Venom PLA 2 Enzymes: An Overview of Its Elusive Mechanisms of Reaction
Castro-Amorim, J., de Oliveira, A. L. N., Silva, S. L. D., Soares, A. M., Mukherjee, A. K., Ramos, M. J., & Fernandes, P. A. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00097 · Cited by 97
Lewin, M. R., Carter, R. W., Matteo, I. A., Samuel, S. P., Rao, S., Fry, B. G., & Bickler, P. E. (2022) · Toxins · doi:10.3390/toxins14110783 · Cited by 94
Hypotensive Snake Venom Components—A Mini-Review
Péterfi, O., Boda, F., Szabó, Z., Ferencz, E., & Bába, L.-I. (2019) · Molecules · doi:10.3390/molecules24152778 · Cited by 91
“Snake venom PLA2s are present in the venoms of species from the Colubridae, Elapidae and Viperidae snake families and they are one of the major toxic components with a wide spectrum of pharmacological effects [94].”
Background
Metadata
- Authors
- Xiao, H., Pan, H., Liao, K., Yang, M., & Huang, C.
- Affiliations
- Nanchang University (CN)
- Corresponding author
- Huang, Chunhong
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-10
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC5727668
- OpenAlex
- W2773445094
- Cited by
- 113
- References
- 95
- Citations by year
- 2026: 19 · 2025: 16 · 2024: 16 · 2023: 13 · 2022: 15 · 2021: 5 · 2020: 10 · 2019: 11 · 2018: 8
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (31260209, 31460227, 20171BAB204015, 20171BCB23018)
- Natural Science Foundation of Jiangxi Province (31260209, 31460227, 20171BAB204015, 20171BCB23018)
- Cultivating Foundation of Young Scientists of Jiangxi Province (31260209, 31460227, 20171BAB204015, 20171BCB23018)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Venomous Animal Envenomation and Studies
- Health Sciences › Medicine › Pharmacology (medical) › Healthcare and Venom Research
- Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Amphibian and Reptile Biology
- Keywords
- snake venom phospholipase A2, snakebite, venomous snakes, Viperidae, Elapidae, Colubridae
- MeSH terms
- Animals, Antivenins, Drug Stability, Humans, Snake Venoms, Phospholipases A2, Phospholipase A2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Snake Venom PLA 2 , a Promising Target for Broad-Spectrum Antivenom Drug Development. https://app.cochat.ai/papers/10.1155/2017/6592820
- The paper
- Xiao, H., Pan, H., Liao, K., Yang, M., & Huang, C. (2017). Snake Venom PLA 2 , a Promising Target for Broad-Spectrum Antivenom Drug Development. BioMed Research International. https://doi.org/10.1155/2017/6592820
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.